Ardigen products

Accelerate discovery and improve safety of TCR therapies using Artificial Intelligence. Following the unique opportunity for curing patients provided by the development of cell therapies (e.g. TCR discovery), Ardigen has set on the path to advance the field with its Artificial Intelligence platform. Many challenges stand in the way of successful therapy discovery and development. Let us know how we can help you!

Quick solution for effective immune responses in clinical trials; We have created an Artificial Intelligence platform dedicated to being a part of the therapeutic cancer vaccine development. The ArdImmune Vax platform uses sequencing data to generate and prioritize antigen targets for cancer vaccines and T-cell therapies.

We solve your problems by combining our expertise into the Ardigen Microbiome Translational Platform.

Accelerated learning to reveal more from your biopsy results; Our platform enables you to process whole-slide biopsy images in a scalable manner, without any loss of information contained in the image and with instant quality check and image standardization. Moreover, it  highlights  areas that contain pathological changes and performs automatic segmentation of the tissue. This process can be applied to various scoring systems, such as the Nancy and Geboes Histological score (for inflammatory bowel disease data) or the Gleason score (for prostate cancer data).

The Ardigen platform is applying various algorithms, deep neural networks and machine learning techniques for analyzing biomedical images to help scientists and physicians understand and predict the behavior of complex biological systems. We strive to improve accuracy and efficiency of diagnostic and therapeutic procedures by utilizing our biomedical computing competences such as: digital image acquisition, processing, quantitative analysis and artificial intelligence in biomedicine; as well as human-computer-interaction and user experience engineering.

Bioinformatics Analysis & Drug Discovery in the era of Artificial Intelligence. The digital CRO team brings together scientists and engineers with diverse skill sets, ranging from biology and chemistry to statistics and machine learning. We work with both small startups and big pharmas to leverage digital power in order to enable the development of new therapies. We contribute to the entire drug discovery process, from target identification and validation, to compound design and clinical trials. We make bioinformatic workflows and software with human-readable code, as well as machine learning models that “understand” biological data and provide cutting-edge solutions for Precision Medicine.